GE HealthCare Technologies Inc. $GEHC Shares Bought by US Bancorp DE

Key Points

• US Bancorp DE increased its holdings in GE HealthCare Technologies by 4.4% in Q2, owning approximately 0.07% of the company, worth about $23.5 million.
• GE HealthCare Technologies reported earnings of $1.06 per share, exceeding the consensus estimate of $0.91, with revenues totaling $5 billion for the quarter.
• The company declared a quarterly dividend of $0.035 per share, to be paid on November 14th, representing an annualized yield of 0.2%.

US Bancorp DE grew its holdings in GE HealthCare Technologies Inc. (NASDAQ:GEHC - Free Report) by 4.4% in the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 317,125 shares of the company's stock after buying an additional 13,261 shares during the quarter. US Bancorp DE owned about 0.07% of GE HealthCare Technologies worth $23,489,000 at the end of the most recent quarter.

Several other hedge funds have also modified their holdings of the business. Glenview Trust co lifted its holdings in shares of GE HealthCare Technologies by 4.4% in the 1st quarter. Glenview Trust co now owns 3,294 shares of the company's stock valued at $266,000 after buying an additional 139 shares during the period. Silver Oak Securities Incorporated lifted its holdings in shares of GE HealthCare Technologies by 4.6% in the 2nd quarter. Silver Oak Securities Incorporated now owns 3,183 shares of the company's stock valued at $236,000 after buying an additional 140 shares during the period. Chicago Capital LLC lifted its holdings in shares of GE HealthCare Technologies by 2.2% in the 2nd quarter. Chicago Capital LLC now owns 6,551 shares of the company's stock valued at $485,000 after buying an additional 141 shares during the period. Fort Washington Investment Advisors Inc. OH lifted its holdings in shares of GE HealthCare Technologies by 4.2% in the 2nd quarter. Fort Washington Investment Advisors Inc. OH now owns 3,557 shares of the company's stock valued at $263,000 after buying an additional 143 shares during the period. Finally, Knuff & Co LLC lifted its holdings in shares of GE HealthCare Technologies by 1.5% in the 1st quarter. Knuff & Co LLC now owns 10,276 shares of the company's stock valued at $829,000 after buying an additional 150 shares during the period. 82.06% of the stock is owned by institutional investors and hedge funds.

GE HealthCare Technologies Stock Performance

GE HealthCare Technologies stock opened at $71.01 on Friday. The company has a debt-to-equity ratio of 0.85, a quick ratio of 0.93 and a current ratio of 1.16. The stock has a fifty day moving average of $74.31 and a two-hundred day moving average of $72.34. The company has a market capitalization of $32.42 billion, a price-to-earnings ratio of 14.55, a PEG ratio of 2.84 and a beta of 1.13. GE HealthCare Technologies Inc. has a fifty-two week low of $57.65 and a fifty-two week high of $94.80.

GE HealthCare Technologies (NASDAQ:GEHC - Get Free Report) last released its quarterly earnings results on Wednesday, July 30th. The company reported $1.06 earnings per share for the quarter, topping the consensus estimate of $0.91 by $0.15. The company had revenue of $5 billion during the quarter, compared to the consensus estimate of $4.96 billion. GE HealthCare Technologies had a return on equity of 23.93% and a net margin of 11.22%.GE HealthCare Technologies's revenue was up 3.5% compared to the same quarter last year. During the same quarter last year, the business posted $1.00 earnings per share. GE HealthCare Technologies has set its FY 2025 guidance at 4.430-4.630 EPS. On average, analysts anticipate that GE HealthCare Technologies Inc. will post 4.68 EPS for the current fiscal year.

GE HealthCare Technologies Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, November 14th. Shareholders of record on Friday, October 24th will be given a dividend of $0.035 per share. The ex-dividend date of this dividend is Friday, October 24th. This represents a $0.14 annualized dividend and a yield of 0.2%. GE HealthCare Technologies's dividend payout ratio (DPR) is presently 2.87%.

Analyst Ratings Changes

GEHC has been the subject of several recent analyst reports. Weiss Ratings reissued a "hold (c)" rating on shares of GE HealthCare Technologies in a report on Saturday, September 27th. Wall Street Zen downgraded GE HealthCare Technologies from a "buy" rating to a "hold" rating in a research note on Saturday, September 20th. Citigroup downgraded GE HealthCare Technologies from a "buy" rating to a "neutral" rating and dropped their price objective for the company from $93.00 to $83.00 in a research note on Tuesday. Morgan Stanley set a $74.00 price objective on GE HealthCare Technologies in a research note on Thursday, September 18th. Finally, Zacks Research downgraded GE HealthCare Technologies from a "strong-buy" rating to a "hold" rating in a research note on Monday, September 29th. Six research analysts have rated the stock with a Buy rating and five have given a Hold rating to the company's stock. According to data from MarketBeat, GE HealthCare Technologies currently has a consensus rating of "Moderate Buy" and a consensus price target of $85.78.

About GE HealthCare Technologies

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.

Want to see what other hedge funds are holding GEHC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for GE HealthCare Technologies Inc. (NASDAQ:GEHC - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.